Autoantibodies may be disabling one of the body's anti-inflammatory brakes in some IBD patients, a new study finds.

For children with suspected inflammatory bowel disease (IBD), a chronic, relapsing condition of the gastrointestinal tract, ...

For children with suspected inflammatory bowel disease (IBD), a chronic, relapsing condition of the gastrointestinal tract, ...

Past research shows that it can be challenging to detect pre-cancerous cells in people with IBD. Researchers from The Institute of Cancer Research in London have developed a new test that they report ...

In the largest genetic study of inflammatory bowel disease (IBD) traits to date, researchers have identified a genetic marker ...

A test that rapidly detects signs of inflammatory bowel disease (IBD) in stool samples could improve future diagnosis and monitoring of the condition, a study suggests. Scientists have developed a ...

A new Crohn's & Colitis Foundation–led survey of more than 1,500 people living with or at risk for inflammatory bowel disease (IBD) found that 93% would be interested in a test to predict their or ...

A test that rapidly detects signs of inflammatory bowel disease (IBD) in stool samples could improve future diagnosis and monitoring of the condition, a study suggests. Scientists have developed a ...

Scientists have developed a tool to measure the activity of a molecule linked to gut inflammation within faecal samples. The optical tool, known as a luminescent reporter, lights up when it detects ...

Study underscores the importance of integrating patient and family perspectives into emerging IBD prevention frameworks, like models used in type 1 diabetes NEW YORK, NY (January 13, 2026) — A new ...

ORLANDO -- Patients with inflammatory bowel disease (IBD) reported mostly favorable responses with the use of mail-order kits for stool sample collections, according to a survey study. Among survey ...

Scientists are working on a new test to predict colorectal cancer in IBD patients. South_agency/Getty Images Now, researchers from The Institute of Cancer Research in London have developed a new test ...